June 19-20, 2023 | Edinburgh, Scotland

17th International Conference on Alzheimer's disease and Dementia

https://alzheimersdisease.neuroconferences.com/ 

Cordially invites you to contribute (conference, symposium, workshop, association meeting, project dissemination meeting, special session, etc.) to the 17th International Conference on Alzheimer's disease and Dementia. This will be held on June 19-20, 2023 in Edinburgh, Scotland. This conference has twenty tracks on which we will discuss. We welcome eminent scholars from all over the world. There are currently 44 million people living with dementia worldwide; it is estimated that this number will double by 2030 and more than treble to 115 million by 2050. Today, this illness is present in more than 35 million people worldwide. Given the complexity of Alzheimer's disease, it is unlikely that any one medication or other treatment will be able to effectively manage it. Although there is currently no cure for Alzheimer's, there are treatments for the symptoms, and research is ongoing. Dementia is predicted to affect 1.4 million Canadians in 20 years, costing the country's economy close to $300 billion annually.

The dementia therapeutics market is valued at USD 13,459.39 million in 2021, growing at a CAGR of 8.28% over the forecast period (2022-2027). The dementia drug market is expected to be significantly impacted by the COVID-19 pandemic. A person with dementia has a higher risk of contracting her COVID-19, according to a study titled "Impact of the COVID-19 Pandemic."

This is our supporting journal Journal of Alzheimers Disease & Parkinsonism, Journal of Spine & Neurosurgery and The Neurosurgery Journal where we will publish your article.

Why to attend?

All those involved in the study of dementia and Alzheimer's disease will have the chance to discuss cutting-edge research at Alzheimer’s Disease- 2023. The Dementia Conference will bring together eminent speakers, neurology experts, and dementia researchers from the academic and healthcare sectors to exchange ideas and research. Sessions presented by top experts in the field of neurology will make up the conference. International symposiums, B2B conferences, and international workshops will be held during the Alzheimer conference meet in 2023 to discuss specific issues related to Alzheimer's and dementia disease.

The International Conference on Alzheimer's Disorders and Disease aims to be an exceptional program of interaction of views and authoritative views by leading scientists that cover the entire spectrum of investigation in mental disorders and share cross-cultural experiences of multiple treatment processes. The main objective of this event is to distribute the current research, revolutions, advance methods and techniques which are practical in the field of mental disorders and disease.

Alzheimer’s RENOWNED SPEAKERS

Konstantin Slavin

University of Illinois

USA

Durodami Lisk

University of Sierra Leone

USA

Cigdem Akman

Columbia University

USA

Diana Kljenak

University of Toronto

Canada

Brent Harris

Georgetown University Hospital

USA

Tomson Louis | Program Manager

Alzheimers Disease 2023

Date: 19-20 June 2023

Email: alzheimerdementia@meconferences.org

Toll Free Number: 0800-014-8923